M Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 13

Professionals

  • Investments
  • 189

  • Portfolio
  • 78

  • Exits
  • 35

Exits

M Ventures General Information

Company Description

Founded in 2009, M Ventures is a corporate venture capital investment arm of Merck headquartered in Amsterdam, Netherlands. The firm invests in biotechnology and technology sectors. The firm focuses on the areas of healthcare drug development, life science tools, electronics, and frontier technology & sustainability.

Business Details

Formerly Known As
MS Ventures
Year Founded
2009
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • Eduard van
  • Beinumstraat 26
  • 1077 CZ Amsterdam
  • Netherlands

M Ventures Investments (189)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Actithera 09-Jul-2025 Early Stage VC Biotechnology Pre-Clinical Trials
ReproNovo 20-May-2025 Other Healthcare Services Clinical Trials - Phase 2
ChEmpower 15-May-2025 Other Commercial Products Generating Revenue
Biolinq 22-Apr-2025 Monitoring Equipment Clinical Trials - Phase 2
MemryX 27-Mar-2025 Application Specific Semiconductors Generating Revenue
TRIMTECH Therapeutics 05-Mar-2025 Drug Discovery Startup
SeeQC 23-Jan-2025 Application Specific Semiconductors Generating Revenue
NovoLINC 21-Jan-2025 Computers, Parts and Peripherals Startup
Klarna 20-Jan-2025 Later Stage VC Financial Software Profitable
Pictor Labs 16-Jan-2025 Later Stage VC Diagnostic Equipment Generating Revenue
You’re viewing 10 of 189 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

M Ventures Exits (35)

Company Name Exit Date Exit Type Exit Size
Tignis 07-Jan-2025 Merger/Acquisition
Scipio Bioscience 18-Sep-2024
Sentaur Biosciences 02-Mar-2024
Metabomed 08-Feb-2024
Calypso Biotech 07-Jan-2024
Macrophage Pharma 05-Dec-2023
Synaffix 31-May-2023
Immunorizon 15-Feb-2023
Vaximm 03-Nov-2022 Secondary Transaction - Private
Aveni 05-Sep-2022 Bankruptcy: Liquidation
You’re viewing 10 of 35 exits. Get the full list »

M Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

M Ventures FAQs

  • What is M Ventures?

    Founded in 2009, M Ventures is a corporate venture capital investment arm of Merck headquartered in Amsterdam, Netherlands.

  • When was M Ventures founded?

    M Ventures was founded in 2009.

  • Where is M Ventures headquartered?

    M Ventures is headquartered in Amsterdam, Netherlands.

  • What is M Ventures's total asset value?

    M Ventures has around in total assets under management.

  • How many investments has M Ventures made?

    M Ventures has made 189 investments.

  • What has M Ventures invested in?

    M Ventures has made numerous investments in companies like Actithera, ReproNovo, and ChEmpower within the Biotechnology, Healthcare Services, and Commercial Products industries.

  • What has M Ventures invested in recently?

    M Ventures's latest investment was on 09-Jul-2025 in Actithera, a company within the Biotechnology industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »